ASXC

Asensus Surgical, Inc.

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price
Ask Price
News -
Company Name Stock Ticker Symbol Market Type
Asensus Surgical, Inc. ASXC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% -
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 USD

Period:

Draw Mode:

Asensus Surgical, Inc. Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 194.42M 236.84M 234.57M $ 8.23M $ - -0.28 -2.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 3.20%

more financials information »

Asensus Surgical, Inc. News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASXC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Asensus Surgical, Inc. Description

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.